MHC recognition by hapten-specific HLA-A2-restricted CD8+ CTL
- PMID: 12928367
- DOI: 10.4049/jimmunol.171.5.2233
MHC recognition by hapten-specific HLA-A2-restricted CD8+ CTL
Abstract
T cell recognition by peptide-specific alphabeta TCRs involves not only recognition of the peptide, but also recognition of multiple molecular features on the surface of the MHC molecule to which the peptide has been bound. We have previously shown that TCRs that are specific for five different peptides presented by HLA-A2 recognize similar molecular features on the surface of the alpha1 and alpha2 helices of the HLA-A2 molecule. We next asked whether these same molecular features of the HLA-A2 molecule would be recognized by hapten-specific HLA-A2-restricted TCRs, given that hapten-specific T cells frequently show reduced MHC dependence/restriction. The results show that a panel of CD8+ CTL that are specific for the hapten DNP bound to two different peptides presented by HLA-A2 do the following: 1) show stringent MHC restriction, and 2) are largely affected by the same mutations on the HLA-A2 molecule that affected recognition by peptide-specific CTL. A small subset of this panel of CD8+ CTL can recognize a mutant HLA-A2 molecule in the absence of hapten. These data suggest that TCR recognition of a divergent repertoire of ligands presented by HLA-A2 is largely dependent upon common structural elements in the central portion of the peptide-binding site.
Similar articles
-
Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexes.J Immunol. 2003 Sep 15;171(6):3064-74. doi: 10.4049/jimmunol.171.6.3064. J Immunol. 2003. PMID: 12960332
-
MHC allele-specific molecular features determine peptide/HLA-A2 conformations that are recognized by HLA-A2-restricted T cell receptors.J Immunol. 2002 Sep 15;169(6):3146-54. doi: 10.4049/jimmunol.169.6.3146. J Immunol. 2002. PMID: 12218132
-
Extensive T cell receptor cross-reactivity on structurally diverse haptenated peptides presented by HLA-A2.Mol Immunol. 2006 Feb;43(4):346-56. doi: 10.1016/j.molimm.2005.02.011. Mol Immunol. 2006. PMID: 16310048
-
Structural and functional distinctiveness of HLA-A2 allelic variants.Immunol Res. 2012 Sep;53(1-3):182-90. doi: 10.1007/s12026-012-8295-5. Immunol Res. 2012. PMID: 22434516 Review.
-
The multiple roles of the CD8 coreceptor in T cell biology: opportunities for the selective modulation of self-reactive cytotoxic T cells.J Leukoc Biol. 2011 Dec;90(6):1089-99. doi: 10.1189/jlb.0611316. Epub 2011 Sep 27. J Leukoc Biol. 2011. PMID: 21954283 Review.
Cited by
-
Increased immunogenicity of an anchor-modified tumor-associated antigen is due to the enhanced stability of the peptide/MHC complex: implications for vaccine design.J Immunol. 2005 Apr 15;174(8):4812-20. doi: 10.4049/jimmunol.174.8.4812. J Immunol. 2005. PMID: 15814707 Free PMC article.
-
Characterization of the Class I MHC Peptidome Resulting From DNCB Exposure of HaCaT Cells.Toxicol Sci. 2021 Feb 26;180(1):136-147. doi: 10.1093/toxsci/kfaa184. Toxicol Sci. 2021. PMID: 33372950 Free PMC article.
-
Nonstimulatory peptide-MHC enhances human T-cell antigen-specific responses by amplifying proximal TCR signaling.Nat Commun. 2018 Jul 13;9(1):2716. doi: 10.1038/s41467-018-05288-0. Nat Commun. 2018. PMID: 30006605 Free PMC article.
-
Enhanced antitumor effect of cytotoxic T lymphocytes induced by dendritic cells pulsed with colorectal cancer cell lysate expressing α-Gal epitopes.Oncol Lett. 2019 Jul;18(1):864-871. doi: 10.3892/ol.2019.10376. Epub 2019 May 20. Oncol Lett. 2019. PMID: 31289564 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials